Dmitry Balyasny’s Revolution Medicines RVMD Stock Holding History

Dmitry Balyasny’s Portfolio RVMD Stock Details RVMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$655K	Sell	3,500 -46,500	-93%	-$6.79M	﹤0.01%	2408
2026 Q1	$4.86M	Buy	+50,000	New	+$5.05M	0.01%	1372

Other funds holding RVMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

DGM

Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Dmitry Balyasny's RVMD Position: Q2 2026 in Review

Dmitry Balyasny sold out of Revolution Medicines (RVMD) in Q2 2026, closing a stake of 23,799 shares — an estimated $3.48M sold.

Dmitry Balyasny first reported a position in RVMD in Q1 2021 and held it in 11 quarters. The position peaked at $91.7M in Q2 2024. 688 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

Dmitry Balyasny reported no remaining Revolution Medicines position as of Q2 2026 after selling out during the quarter.
Dmitry Balyasny sold 23,799 Revolution Medicines shares in Q2 2026, an estimated $3.48M.
Dmitry Balyasny first reported a position in Revolution Medicines in Q1 2021 and held it in 11 quarters.
Dmitry Balyasny's Revolution Medicines position peaked at $91.7M in Q2 2024.
688 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.